Literature DB >> 9560028

Measured and predicted bone mineral content in healthy boys and girls aged 6-18 years: adjustment for body size and puberty.

J T Warner1, F J Cowan, F D Dunstan, W D Evans, D K Webb, J W Gregory.   

Abstract

Dual-energy X-ray absorptiometry (DEXA) is a rapid and precise technique for the assessment of bone mineralization in children. Interpretation of the results in growing children is complex as results are influenced by age, body size (height and weight) and puberty. Conventionally, bone mineral data derived from DEXA have been presented as an areal density [BMD; bone mineral content (BMC, g)/projected bone area (BA, cm2)], yet this fails to account for changes in BMC that result from changes in age, body size or pubertal development. Measurement of BMC and BA of the whole body, lumbar spine and left hip were made in 58 healthy boys and girls using DEXA. The relationship between BMC and BA was curvilinear, with the best fit being that of a power model (BMD = BMC/BAlambda, where lambda is the exponent to which BA is raised in order to remove its influence on BMC). The value of lambda changed when measures of body size and puberty were taken into account (e.g. for lumbar spine from 1.66 to 1.49). Predictive formulae for BMC were produced using regression analysis and based on the variables of age, body size and pubertal development. This provides a method for interpreting the measured BMC which is independent of such variables and a constant reference range for children aged 6-18 y.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9560028     DOI: 10.1080/08035259850157264

Source DB:  PubMed          Journal:  Acta Paediatr        ISSN: 0803-5253            Impact factor:   2.299


  19 in total

1.  The differing tempo of growth in bone size, mass, and density in girls is region-specific.

Authors:  S Bass; P D Delmas; G Pearce; E Hendrich; A Tabensky; E Seeman
Journal:  J Clin Invest       Date:  1999-09       Impact factor: 14.808

2.  Metabolic effects of discontinuing growth hormone treatment.

Authors:  F J Cowan; W D Evans; J W Gregory
Journal:  Arch Dis Child       Date:  1999-06       Impact factor: 3.791

3.  Bone densitometry in children assessed by dual x ray absorptiometry: uses and pitfalls.

Authors:  M S Fewtrell
Journal:  Arch Dis Child       Date:  2003-09       Impact factor: 3.791

4.  Bone mineral mass in males and females with and without Down syndrome.

Authors:  Fatima Baptista; Ana Varela; Luis B Sardinha
Journal:  Osteoporos Int       Date:  2004-09-09       Impact factor: 4.507

5.  Total and regional bone mineral content in healthy Spanish subjects by dual-energy X-ray absorptiometry.

Authors:  S Aguado Henche; R Rodríguez Torres; C Clemente de Arriba; L Gómez Pellico
Journal:  Skeletal Radiol       Date:  2008-07-02       Impact factor: 2.199

6.  Bone mineral content, corrected for height or bone area, measured by DXA is not reduced in children with chronic renal disease or in hypoparathyroidism.

Authors:  S Faisal Ahmed; Shiuli Russell; Rajeeb Rashid; T James Beattie; Anna V Murphy; Ian J Ramage; Heather Maxwell
Journal:  Pediatr Nephrol       Date:  2005-07-27       Impact factor: 3.714

7.  Reference data for bone density and body composition measured with dual energy x ray absorptiometry in white children and young adults.

Authors:  I M van der Sluis; M A J de Ridder; A M Boot; E P Krenning; S M P F de Muinck Keizer-Schrama
Journal:  Arch Dis Child       Date:  2002-10       Impact factor: 3.791

8.  Pediatric reference curves for multi-site quantitative ultrasound and its modulators.

Authors:  Zvi Zadik; Dario Price; Gary Diamond
Journal:  Osteoporos Int       Date:  2003-08-12       Impact factor: 4.507

9.  Bone mass and density in preadolescent boys with and without Down syndrome.

Authors:  J Wu
Journal:  Osteoporos Int       Date:  2013-05-17       Impact factor: 4.507

10.  Lower bone mineral density in children with type 1 diabetes is associated with poor glycemic control and higher serum ICAM-1 and urinary isoprostane levels.

Authors:  Kaire Heilman; Mihkel Zilmer; Kersti Zilmer; Vallo Tillmann
Journal:  J Bone Miner Metab       Date:  2009-04-17       Impact factor: 2.626

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.